Glycosylated Chitosan Inhibits Pancreatic Cancer Metastasis by Blocking the Caveolin Signaling Pathway
Cancers · 03.05.2026 · 18 (9) · 1473
DOI: 10.3390/cancers18091473 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 03.05.2026. Verfasst von Yong Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Key Laboratory of Cancer Prevention and Therapy, Interventional Therapy Department, Tianjin Medical University Cancer Institute and Hospital,…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation for the National Institutes of Health, US National Institutes of Health, OU Libraries’ Open Access Fund.
Abstract (Originalsprache)
Background and Objectives: Pancreatic cancer is highly metastatic, and metastasis is the main cause of cancer-related deaths. Therefore, finding methods to inhibit pancreatic cancer metastasis has important clinical value.
Methods
N-dihydrogalactochitosan (GC) is an immunostimulant that can enhance the anti-tumor immune response to inhibit metastasis in combination with photothermal therapy.
Results
Here, we found that GC can inhibit the migration of pancreatic cancer cells through interactions with caveolin-1 (Cav-1). The fluorescence of GC-FITC on the cell surface overlaps with Cav-1-Red, is enhanced by adCav-1, and is weakened by siCav-1, indicating that the localization of GC depends on Cav-1. GC inhibits the migration of malignant cells by blocking the signal transduction of Cav-1 and its downstream molecules. In an orthotopic pancreatic tumor model, GC can inhibit tumor metastasis in tumor-bearing mice.
Conclusions
These results demonstrate GC’s capacity to act as a partner in pancreatic cancer therapy and indicate future directions for metastatic cancer therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Tianjin Key Laboratory of Cancer Prevention and Therapy, Interventional Therapy Department, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
- Biophotonics Research Laboratory, Center for Interdisciplinary Biomedical Education and Research, College of Mathematics and Science, University of Central Oklahoma, Edmond, OK 73034, USA.
- Stephenson School of Biomedical Engineering, The University of Oklahoma, Norman, OK 73019, USA.
- Hematology-Oncology, Department of Internal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
- VA-MD College of Veterinary Medicine, Virginia Tech, Blacksburg, VA 24061, USA.
ORCID-Profile: Jingxuan Yang, Abigael P Williams, Joanne Tuohy
Förderung
- Foundation for the National Institutes of Health
- US National Institutes of Health
- OU Libraries’ Open Access Fund
Zitieren
APA
Li, Y., Adams, J. P., Yang, J., Williams, A. P., Li, M., Tuohy, J., & Chen, W. R. (2026). Glycosylated Chitosan Inhibits Pancreatic Cancer Metastasis by Blocking the Caveolin Signaling Pathway. Cancers, 18(9), 1473. https://doi.org/10.3390/cancers18091473
Vancouver
Li Y, Adams JP, Yang J, Williams AP, Li M, Tuohy J, et al. Glycosylated Chitosan Inhibits Pancreatic Cancer Metastasis by Blocking the Caveolin Signaling Pathway. Cancers. 2026;18(9):1473. doi:10.3390/cancers18091473
BibTeX
@article{Li2026,
author = {Li, Yong and Adams, Jacob Paul and Yang, Jingxuan and Williams, Abigael P and Li, Min and Tuohy, Joanne and Chen, Wei R},
title = {Glycosylated Chitosan Inhibits Pancreatic Cancer Metastasis by Blocking the Caveolin Signaling Pathway},
journal = {Cancers},
year = {2026},
volume = {18},
number = {9},
pages = {1473},
doi = {10.3390/cancers18091473}
}
EUVIMED